Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraception

Contraception

Volumn 89, Issue 5, 2014, Pages 451-459

  Trussell, James ^a,b   Hassan, Fareen ^c   Henry, Nathaniel ^c   Pocoski, Jennifer ^d   Law, Amy ^d   Filonenko, Anna ^e  

^a PRINCETON UNIVERSITY   (United States)

^b UNIVERSITY OF HULL   (United Kingdom)

^c IQVIA   (United States)

^d Bayer HealthCare Pharmaceuticals Inc   (United States)

^e BAYER PHARMA AG   (Germany)

Author keywords

Contraception; Cost effectiveness; Economic evaluation; Levonorgestrel releasing intrauterine system; Long acting reversible contraception; Unintended pregnancy

Indexed keywords

LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CONSULTATION; CONTRACEPTION; CONTRACEPTIVE DEVICE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; ECTOPIC PREGNANCY; FEMALE; HEALTH CARE COST; HEALTH STATUS; HUMAN; INDUCED ABORTION; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; LIVE BIRTH; MAJOR CLINICAL STUDY; SENSITIVITY ANALYSIS; SHORT ACTING REVERSIBLE CONTRACEPTION; SPONTANEOUS ABORTION; UNITED STATES; UNPLANNED PREGNANCY; VAGINA RING; COST BENEFIT ANALYSIS; ECONOMICS; STATISTICAL MODEL;

CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MODELS, ECONOMIC;

EID: 84900343592     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2013.10.019     Document Type: Article

References (32)

1. L.B. Finer, and M.R. Zolna Unintended pregnancy in the United States: incidence and disparities, 2006 Contraception 84 2011 478 485
2. J. Trussell The cost of unintended pregnancy in the United States Contraception 75 2007 168 170
3. J. Trussell, N. Henry, F. Hassan, A. Prezioso, A. Law, and A. Filonenko Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception Contraception 87 2012 154 161
4. F.A. Sonnenberg, R.T. Burkman, C.G. Hagerty, L. Speroff, and T. Speroff Costs and net health effects of contraceptive methods Contraception 69 2004 447 459
5. J. Trussell, A.M. Lalla, Q.V. Doan, E. Reyes, L. Pinto, and J. Gricar Cost effectiveness of contraceptives in the United States Contraception 79 2009 5 14
6. J.D. Koenig, M.J. Strauss, J. Henneberry, and T.G. Wilson The social costs of inadequate contraception Int J Technol Assess 12 1996 487 497
7. J. Jones, W.D. Mosher, and K. Daniels Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995. National health statistics reports; no 60 2012 National Center for Health Statistics Hyattsville, MD 2012
8. J. Trussell Contraceptive failure in the United States Contraception 83 2011 397 404
9. I. Mavranezouli The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline Hum Reprod 23 2008 1338 1345
10. Bayer HealthCare Pharmaceuticals Inc. MIRENA™ [prescribing information]. Wayne, NJ; February 2013. http://labeling.bayerhealthcare.com/ html/products/pi/Mirena-PI.pdf.
11. Teva Women's Health Inc. PARAGARD® [prescribing information]. Sellersville, PA; 2013. http://www.paragard.com/images/ParaGard-info.pdf.
12. A. Nelson, D. Apter, B. Hauck, S. Rybowski, K. Rosen, and K. Gemzell-Danielsson A global, randomized, phase III, pearl index study comparing the efficacy and safety of two low-dose levonorgestrel-releasing intrauterine systems (LNG-IUS) in nulliparous and parous women Fertil Steril 98 2012 S5
13. U.S.Department of Health & Human Services. News Release: A statement by U.S. Department of Health and Human Services Secretary Kathleen Sebelius. 2012. http://www.hhs.gov/news/press/2012pres/01/20120120a.html. Accessed January 30, 2013.
14. S.J. Ventura, S.C. Curtin, J.C. Abma, and S.K. Henshaw Estimated pregnancy rates and rates of pregnancy outcomes for the United States, 1990-2008. National vital statistics reports; vol 60, no 7 2012 National Center for Health Statistics Hyattsville, MD
15. Kavanaugh et al. 2012. Long-acting Reversible Contraception for Adolescents and Young Adults: Patient and Provider Perspectives.
16. B. Vaughan, J. Trussell, K. Kost, S. Singh, and R. Jones Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family Growth Contraception 78 4 2008 271 283
17. Bayer HealthCare Pharmaceuticals Inc. SKYLA™ [prescribing information]. Wayne, NJ; February 2013. http://labeling.bayerhealthcare.com/ html/products/pi/Skyla-PI.pdf.
18. L.B. Finer, and S.K. Henshaw Disparities in rates of unintended pregnancy in the United States, 1994 and 2001 Perspect Sex Reprod Health 38 2006 90 96
19. Wolters Kluwer Health. Medi-Span Master Drug Database. 2012. http://www.medi-span.com/drug-pricing-analysis-pricerx.aspx. Accessed May 17, 2012.
20. Centers for Medicare & Medicaid Services. Medicare Physician Fee Schedule, CPT Code Book and Medicare Outpatient Prospective Payment System. 2012. https://www.cms.gov/home/medicare.asp. Accessed May 17, 2012.
21. HCUPnet. Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality, Rockville, MD. 2012. http://hcupnet.ahrq.gov. Accessed May 17, 2012.
22. Medicare Payment Advisory Commission. Report to the Congress: Medicare Payment Policy - Section 2B Physician Services. 2007. http://www.medpac.gov/ chapters/Mar07-Ch02b.pdf. Accessed May 17, 2012.
23. W.D. Mosher, J. Jones, and J.C. Abma Intended and unintended births in the United States: 1982-2010. National health statistics reports; no 55 2012 National Center for Health Statistics Hyattsville, MD
24. K.W. Hoover, G. Tao, and C.K. Kent Trends in the diagnosis and treatment of ectopic pregnancy in the United States Obstet Gynecol 115 2010 495 502
25. J.F. Peipert, Q. Zhao, J.E. Allsworth, E. Petrosky, T. Madden, and D. Eisenberg et al. Continuation and satisfaction of reversible contraception Obstet Gynecol 117 5 2011 1105 1113
26. K. Kost, S. Singh, B. Vaughan, J. Trussell, and A. Bankole Estimates of contraceptive failure from the 2002 National Survey of Family Growth Contraception 77 1 2008 10 21
27. Centers for Disease Control and Prevention, National Survey of Family Growth, http://www.cdc.gov/nchs/nsfg/about-nsfg.htm; 2012.
28. J. Trussell Contraceptive failure in the United States Contraception 70 2004 89 96
29. C.F. Chiou, J. Trussell, E. Reyes, K. Knight, J. Wallace, and J. Udani et al. Economic analysis of contraceptives for women Contraception 68 2003 3 10
30. I. Mavranezouli Health economics of contraception Best Pract Res Cl Ob 23 2009 187 198
31. The American College of Obstetricians and Gynecologists. Induced Abortions: Frequently asked questions FAQ043 Special Procedures 2011. http://www.acog.org//media/For%20Patients/faq043.pdf?dmc=1&ts= 20130513T0547266679. Accessed January 30, 2013.
32. C.P. Griebel, J. Halvorsen, T.B. Golemon, and A.A. Day Management of spontaneous abortion Am Fam Physician 72 2005 1243 1250